Chapter 1. MAGNETIC PARTICLE IMAGING MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. MAGNETIC PARTICLE IMAGING MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. MAGNETIC PARTICLE IMAGING MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. MAGNETIC PARTICLE IMAGING MARK ET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. MAGNETIC PARTICLE IMAGING MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. MAGNETIC PARTICLE IMAGING MARKET – By Type
6.1. Tracer
6.2. MPI Scanner
6.3. Others
Chapter 7. MAGNETIC PARTICLE IMAGING MARKET – By Modality
7.1. Magnetic Resonance Imaging
7.2. Positron Emission Tomography
Chapter 8. MAGNETIC PARTICLE IMAGING MARKET – By Application
8.1. Vascular Imaging
8.2. Perfusion Imaging
8.3. Blood Pool Imaging
8.4. Neuroimaging
8.5. Localized Hyperthermia
8.6. Oncology Imaging
8.7. Cell Tracking
8.8. Inflammation Imaging
8.9. Trauma Imaging
Chapter 9. MAGNETIC PARTICLE IMAGING MARKET –By End Use
9.1 Hospitals
9.2. Speciality Clinics
Chapter 10. MAGNETIC PARTICLE IMAGING MARKET – By Region
10.1. North America
10.2. Europe
10.3.The Asia Pacific
10.4.Latin America
10.5. Middle-East and Africa
Chapter 11. MAGNETIC PARTICLE IMAGING MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)
11.1. Company 1
11.2. Company 2
11.3. Company 3
11.4. Company 4
11.5. Company 5
11.6. Company 6
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.10. Company 10
2850
5250
4500
1800